Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...
Big Pharma just hiked prices for more than 250 drugs
Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10 ...
Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.
Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Stock market giants including Nvidia and Walmart completed stock splits in 2024. Investors like these operations because they ...
PJP: Big Pharma Concentration Risks Amid Looming Confirmation Of RFK Jr.
This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...
Is Merck the Next Big Weight-Loss Stock?
And that's why Merck could credibly become the next big weight-loss stock. Before you rush to go buy shares of Merck, ...
Nasdaq4d
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Considering this fantastic performance, investors have been wondering whether this big pharma company will launch a stock split. History shows us Lilly is open to such operations because it ...